Waymark

Waymark is a public benefit corporation founded in 2021, focused on transforming healthcare delivery for the historically underserved Medicaid population through community-driven, evidence-based care. Their model emphasizes building multidisciplinary, local care teams—including community health workers, pharmacists, social workers, and medical assistants—that collaborate closely with Medicaid Managed Care Organizations and primary care providers to improve patient outcomes and engagement. The company serves high-need patients by deploying mobile teams and using technology and data science responsibly to identify and support those at risk, aiming to reduce avoidable hospitalizations and emergency visits.

Headquartered in San Francisco, Waymark is committed to bolstering existing primary care rather than replacing it, while creating meaningful, benefited jobs within communities. Their technology platform, including the proprietary Waymark Signal™, employs advanced machine learning to predict and proactively address preventable healthcare utilization with over 90% accuracy. As a public benefit corporation, Waymark prioritizes community benefit and the inclusion of lived experience to guide their solutions, ensuring culturally competent and empathetic care. Their approach has been validated by peer-reviewed studies published as recently as 2024, demonstrating positive clinical outcomes and sustainable cost savings for Medicaid programs.

Waymark currently manages care for tens of thousands of Medicaid patients across regions such as Washington and Virginia, addressing significant market potential in Medicaid Managed Care spending (~$400B in 2021). Their culture emphasizes humility, inclusivity, and the empowerment of community health workers who often share similar backgrounds with the patients they serve, thus fostering trust and more effective care coordination. Overall, Waymark represents an innovative integration of community-based care delivery supported by technology, with a clear focus on equity and scaling impact within the US Medicaid healthcare system.